Mito BioPharma Company

Mito BioPharma is a biopharmaceutical company that focuses on targeting mitochondria and cellular metabolism modulation for development of therapeutics. Mitochondria are at the center of cellular metabolism and alteration in mitochondrial function causally contributes to many diseases such as NASH, type 2 diabetes, lipid disorders, neurodegenerative diseases, cancer, and aging in general. It has long been proposed that these diseases could be effectively treated by modulating or correcting mitochondrial function.
Industry: Mitochondrial Dynamics
Headquarters: United States
Founded Date: 2012

Visit Website
Register and Claim Ownership